GOTHENBURG, SWEDEN / ACCESS Newswire / April 25, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, April 25, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company ...

Anti-IL1RAP ADC demonstrated potent anti-tumor efficacy and was well tolerated in pre-clinical modelsAnti-IL1RAP ADC targets IL1RAP, which is overexpressed in many tumors and their tumor ...

Clinical findings show association between nadunolimab and lower incidence and later onset of CIPNPreclinical data show prevention of both chemotherapy- and antibody-drug conjugate- (ADC) ...

Conference/Scientific publicationPentixapharm to Present First-in-Class Glycan-Dependent CD24 Antibody GT-008 for Solid Tumors at AACR 2025 25.04.2025 / 15:39 CET/CESTThe issuer is solely responsible ...

New Report Ranks Top Vendors and Reveals Strategic ROI Insights from Healthcare Finance Leaders NEW YORK CITY, NEW YORK / ...

GOTHENBURG, SWEDEN / ACCESS Newswire / April 25, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)The following resolutions were passed at the Annual General Meeting (the "AGM") of XVIVO ...

Cipher Surgical Completes $10 Million Series A Funding Round Led by MSI to Drive Global Expansion and Innovation in Surgical Visualization CHANTILLY, VIRGINIA / ACCESS Newswire / April 25, 2025 / ...

NephroDI Therapeutics’ Founder and CMO Jeff M. Sands, M.D. Receives the2025 Robert W. Berliner Award for Excellence in Renal Physiology  April 24, 2025, Seattle, WA – NephroDI Therapeutics (NephroDI), ...

ABB publishes Environmental Product Declaration for distributed control system controllersABB becomes the first company to publish an externally verified Environmental Product Declaration (EPD) for ...

Biologit Boosts Patient Safety with World-First Automated Local Literature Monitoring Solution for Non-Indexed Sources·         Biologit for Local Literature™ delivers results 15 x faster than ...

OncoZenge provides update on regulatory status of incoming investmentOncoZenge AB (publ) ("OncoZenge" or the "Company") today provides an update on the status of the regulatory process in China ...

The pharmaceutical industry is undergoing a transformative era driven by increasingly stringent global regulatory requirements, significantly impacting operational processes, particularly those ...